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 The role of social cognition in severe mental illness (SMI) has gained much 
attention, especially over the last decade. The impact of deficits in socio-cognitive 
functioning has been found to have detrimental effects on key areas of day-to-day 
functioning in individuals with SMI, such as gaining and maintaining employment and 
overall experienced quality of life. Treatment of individuals with SMI is challenging, as 
the presentation of individual signs and symptoms is rather heterogeneous. There are 
several treatment approaches addressing deficits ranging from broader social and 
interpersonal functioning to neurocognitive and more intrapersonal functioning. As 
research in the domain of social cognition continues to identify specific deficits and its 
functional detriments, treatment options need to evolve to better target identified 
functional deficits. Social Cognition and Interaction Training (SCIT) was recently 
developed to address specific socio-cognitive deficits in an inpatient population of 
individuals with schizophrenia-spectrum disorders. This study applied SCIT in an 
outpatient SMI population as many deficits remain after individuals’ symptoms are less 
severe and overall functioning is more stable than during the acute inpatient phase of 
their rehabilitation. Specifically, this study has two objectives. First, to demonstrate that 
deficits in social cognition persist after the acute phase of illness has abated. Second, to 
 demonstrate that these deficits can be ameliorated via targeted treatment such as SCIT. 
Data was gathered in local outpatient treatment settings serving a heterogeneous SMI 
population.   
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Chapter 1 – Introduction 
Social Cognition and Interaction Training (SCIT) for Individuals with Schizophrenia 
Spectrum Disorders in Outpatient Treatment Settings 
Social cognition has been defined as “the ability to construct representations of 
the relations between oneself and others, and to use those representations flexibly to 
guide social behaviors” (Adolphs, 2001). Research has established the adverse impact of 
socio-cognitive dysfunction on clinical as well as functional outcome for individuals with 
schizophrenia spectrum disorders (Brenner et al., 1994; Hogarty & Flesher, 1999). 
Schizophrenia spectrum disorders have wide-ranging and debilitating effects on peoples’ 
lives. Social cognitive deficits have been an important domain of functioning with 
deficits manifested in peoples’ ability to establish and maintain meaningful interpersonal 
relationships to gaining and maintaining employment as well as the overall perceived 
quality of life (Corin & Lauzon, 1994; Davidson, Stayner, & Haglund, 1998; Mueser, 
Becker, & Wolfe, 2001; Mueser, Salyers, & Muser, 2001). Further, cognitive 
impairments (such as deficits in memory, attention, and problem-solving) have been 
found to negatively impact psychosocial functioning (including skills needed in areas of 
vocational attainment and interpersonal functioning) as well as interfere with 
rehabilitation goals overall (Green, 1998; Penn, Corrigan, & Racenstein, 1998); and 
limited social competence has been linked to deficits in cognitive domains such as 
attention and memory (Hogarty, 2000). Using structural equation modeling, Sergi and 
colleagues suggested that social cognition and neurocognition are separate, yet closely 
linked constructs (Sergi, Rassovsky, et al., 2007). As such, social cognition has been 
called a mediator as it bridges more molecular domains (i.e. underlying neuro-cognitive 
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abilities) with a more molar domain, the interactive social realm of functioning (Brekke, 
Kay, Lee, & Green, 2005; Couture, Penn, & Roberts, 2006; Kee, Kern, & Green, 1998; 
Sergi, Rassovsky, Nuechterlein, & Green, 2006). Green, Uhlhass, and Coleheart (2005) 
suggested that functioning in the neurocognitive, socio-cognitive, as well as the broader 
psychosocial domain should be combined for a better understanding not only of 
schizophrenia but also for more informed treatment approaches aimed to improve 
functional outcome in people with serious mental illness (SMI1).  The vulnerability-stress 
or diathesis-stress model (e.g. Zubin & Spring, 1975), and more recently the 
neurodevelopmental model (Murray, O’Callaghan, Castle, & Lewis, 1992) are theoretical 
formulations that incorporate multiple levels of organismic functioning, designed mostly 
to clarify the etiology of SMI. The biosystemic model (e.g. Spaulding, Sullivan, & 
Poland, 2003) is a similar formulation designed mostly to inform clinical assessment, 
treatment and rehabilitation. Together these formulations create the broader theoretical 
paradigm in which current research on social cognitive impairments and their treatment 
proceeds.  
The main hypotheses of this study examined the effectiveness of a newly 
developed treatment approach looking to ameliorate social cognitive functioning in 
individuals with schizophrenia spectrum disorders. The chosen treatment modality, 
Social Cognitive and Interaction Training (SCIT), was developed by Penn et al. at the 
                                                
1 SMI is an umbrella term used in mental health services policy and administration, and 
more generally to connote people with chronic, disabling psychotic disorders including 
schizophrenia and severe affective disorders.  For scientific and scholarly purposes, SMI 
is often, but not always, interchangeable with diagnostic terms such as “schizophrenia” or 
paradiagnostic terms such as “schizophrenia-spectrum.”  In this discussion, SMI refers to 
the broader population, and other terms are used when reviewing specific studies that use 
those terms as inclusion or independent variables. 
3 
University of North Carolina and is currently undergoing rigorous testing in order to be 
established as best practice in the field of SMI treatments. This study hypothesizes that 
individuals receiving SCIT will show improvement in socio-cognitive domains after 
receiving the treatment as compared to individuals who do not receive SCIT treatment. 
As this study employed a waitlist-control format, all participants received SCIT by the 
end of the study. It is hypothesized that by the end of the study, all participants will have 
improved in socio-cognitive domains as addressed by SCIT.  
Study participants were assigned to two groups: 1) SCIT then TAU (treatment as 
usual), or 2) TAU then SCIT. Participants completed a comprehensive testing battery 
three times over the course of the study: pre-treatment (baseline, testing time 1), after the 
first set of SCIT groups ended (half of the participants are post-treatment, testing time 2), 
and again after the second set of SCIT groups ended (all participants are post-treatment, 
testing time 3). The testing battery included measures assessing current symptomatology, 
neurocognitive functioning, and socio-cognitive functioning.  
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Chapter 2 – Literature Review 
Social Cognition in Severe Mental Illness 
The term “social cognition” has gained increased attention, especially during the 
past 15 years, and refers to “mental operations underlying social interactions, which 
include the human ability and capacity to perceive the intentions and dispositions of 
others” (Brothers, 1990). As established by the National Institute of Mental Health 
(NIHM) initiative “Measurement and Treatment Research to Improve Cognition in 
Schizophrenia (MATRICS),” essential components of social cognition include emotion 
perception, social perception, social knowledge, theory of mind (ToM) and metacogntive 
abilities, as well as attributional style (Green, Olivier, Crawley, Penn, & Silverstein, 
2005; Green & Leitman, 2008). However, other studies refer to three (of the above 
named five) components as primary domains: emotion perception, ToM, and attributional 
style (Combs, et al., 2009; Penn, Sanna, & Roberts, 2008).  Of these, emotion perception 
and processing appears to be the most studied area of social cognition (Kee, et al., 2009).  
These findings highlight the need for further study in order to identify the specific factor 
structure and inter-relationships of these overlapping domains of social cognition.   
Research has shown that individuals with schizophrenia-spectrum disorders have 
difficulty with the skills and abilities mentioned above (Edwards, Jackson, & Pattison, 
2002; Corrigan & Nelson, 1998; Corrigan & Toomey, 1995; Addington & Addington, 
1998; Grant et al., 2001; Frith & Corcoran, 1996; Pickup & Frith, 2001). Further, 
research has confirmed that social cognition mediates the relationship between 
neurocognition and functional outcome (Brekke, et al., 2005; Gard, Fisher, Garrett, 
Genevsky, & Vinogradov, 2009; Yager & Ehmann, 2006 ). As such, findings indicate 
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that individuals with schizophrenia-spectrum disorders have difficulty with community 
functioning and social adjustment and has identified cognitive deficits in the areas of 
working memory, executive functioning and attention as underlying factors to these 
socio-cognitive deficits (Green, Kern, Braff, & Mintz, 2000; Tso, Grove, & Taylor, 
2009). In addition, studies utilizing techniques such as functional magnetic resonance 
imaging (fMRI) and regional cerebral blood flow (rCBF) monitoring have found that 
people with schizophrenia-spectrum disorders show a different pattern of brain response 
compared to normal individuals, including deficits in neurochemistry (see West & Grace, 
2001 for a detailed review). Deficits in neural substrates linking the prefrontal regions of 
the brain with other areas (such as the amygdala and the limbic system) have been linked 
to deficits in executive functioning, reasoning, self-awareness, and decision-making 
(Tranel, Bechara, & Damasio, 2000). Such deficits can to some extent be addressed via 
targeted repetitive learning (i.e. strengthening neuro-pathways in the brain), improving 
cognitive control, and the teaching of mature thinking styles (Bell, Bryson, Fiszdon, 
Greig, & Wexler, 2004; Spaulding et al., 1998; Wykes, Reeder, Corner, Williams, & 
Everitt, 1999; Hogarty & Flesher, 1999).  
Treatment of Social Cognitive Deficits 
 Psychopharmacological treatment may help with addressing some of the above 
named deficits. Findings have been mixed in determining the effects of medication, 
especially with regards to the remediation of negative symptoms and cognitive 
impairment. Studies have found that, in contrast to positive symptoms, negative 
symptoms and cognitive impairments tend to be more stable over time and less 
responsive to treatment with antipsychotic medications (Kane & Marder, 1993; Greden & 
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Tandon, 1991).  However, more recent studies found some evidence that atypical 
antipsychotic medications (e.g. olanzapine, risperidone, and clozapine) may have a 
beneficial impact on negative symptoms and cognitive impairments (Meltzer & McGurk, 
1999; Keffe, Silva, Perkins, & Lieberman, 1999; Wahlbeck, Cheine, Essali, & Adams, 
1999). To date, studies specifically focused on the impact of pharmacological treatments 
on socio-cognitive deficits are limited and inconclusive. While some studies found 
treatment with atypical antipsychotic medications improved social perception as 
compared to treatment with conventional antipsychotic medications (Littrell, Petty, 
Hilligoss, Kirshner, & Johnson, 2004; Kee, Kern, Marshall, & Green, 1998), other studies 
did not find any significant effect of pharmacological treatment on emotion perception 
(Harvey, Patterson, Potter, Zhong, & Brecher, 2006; Herbener, Hill, Marvin, & Sweeney, 
2005; Penn, Keefe, Davis, Meyer, Perkins, Losardo, et al., 2009; Sergie, Green, et al., 
2007). Overall, symptom reduction and stabilization often has a positive, if moderate, 
effect on neurocognitive performance, with different medications affecting improvements 
in different areas of cognitive functioning (e.g. verbal fluency, attention) as symptom 
severity improves. Nonetheless, psychopharmacological intervention is just one part of a 
comprehensive as well as individualized treatment approach. 
 Studies have found evidence for a link between cognitive functioning and 
functional outcome in schizophrenia. The impact of change in cognitive functioning, 
however, appears to be mediated by cognitive interventions. Research has found that 
improvement in cognition is not sufficient to lead to functional change unless it is 
achieved via targeted treatments (Wykes & Reeder, 2005). Studies have also focused on 
identifying specific areas of socio-cognitive dysfunction in people with SMI. 
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Furthermore, research has focused on how social cognitive difficulties impact people’s 
lives and how this functional deficit can best be addressed in treatment. As such, research 
has recognized aspects of social cognition as an important part to successful interpersonal 
functioning in persons with schizophrenia (Couture, Penn, & Roberts, 2006; Penn, 
Combs, & Mohmed, 2001). Difficulty with social functioning often adversely impacts a 
person’s overall perceived quality of life (Grant, Addington, Addington, & Konnert, 
2001, Penn, Corrigan, Bentall, Racenstein, & Newman, 1997). Intact social cognitive 
abilities, including adequate social skills, thus impact the quality of social interactions, 
which are an important factor in vocational functioning, establishing and maintaining 
interpersonal friendships and relationships, and achieving a level of functioning sufficient 
for independent community living  (Dickinson, Bellack, & Gold,  2007). Impairment in 
social functioning is also associated with higher relapse rates (Perlick, Stastny, Mattis, & 
Teresi, 1992). These socio-cognitive deficits are best addressed in treatment via a social 
learning approach, including modeling of behaviors and repetitively practicing target 
behaviors in role-plays.  
Existing socio-cognitive treatment modalities. 
 To date, several psychosocial treatment approaches have been developed and 
successfully implemented in the treatment of people with SMI. Treatment format and 
patient population are important characteristics to consider when choosing a specific 
treatment approach for people with SMI. Current treatments for people with 
schizophrenia-spectrum disorders utilize individual as well as group formats. Generally, 
the more “social” treatment approaches tend to utilize a group format, whereas 
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approaches that also target neurocognitive functioning utilize an individual or mixed, 
individual and group, format. 
 Another factor to consider when choosing a specific treatment modality to address 
socio-cognitive deficits is the symptom acuity of the patient. Some treatment modalities 
are formulated targeting either an inpatient or an outpatient patient population; others can 
be adjusted and administered with either group.   
 The following treatments are administered on an individual basis. Although they 
do not specifically target socio-cognitive dysfunction per se, they have been found useful 
in improving functioning in the social cognitive realm.  
 Cognitive remediation therapy (CRT) (Wykes & Reeder, 2005). CRT operates on 
the premise that improvement in cognitive function will affect other functions, such as 
socio-cognitive abilities. Specifically, CRT aims to improve executive functions (e.g. 
planning skills), memory, attention, and the ability for cognitive shift (e.g. shift set). 
Wykes and Reeder (2005) emphasize the importance of explicit teaching of reflective 
processing coupled with practice of learned skills in order to improve metacognitive 
abilities. The authors suggest the use of CRT in people with no co-existing substance 
abuse problem or acquired traumatic brain injury as it would distract from the focus of 
the program and render is much less successful. Similarly, the authors discourage use of 
CRT in people who actively experience psychotic symptoms, as these as well would 
distract from the treatment. In addition to the above named suitability factors, CRT also 
assess participants’ motivation to participate in treatment and, most importantly, 
motivation to change via the process. Sessions are conducted on an individual basis up to 
three times per week. Even though CRT does not specifically focus on either inpatients or 
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outpatients, studies have mostly been recruiting outpatients for treatment for reasons 
mentioned above (e.g. symptom acuity etc). Overall, studies have found that the most 
durable treatment effect was improvement in verbal memory performance. Wykes and 
colleagues (1999) found that CRT participants improved in cognitive flexibility as well as 
memory function. Further, Wykes and colleagues found some skills taught by CRT were 
sustained over the six months after therapy was terminated. Specifically, improved 
cognitive flexibility appeared to be related to changes in social functioning. However, no 
direct effect of therapy on social functioning was found 6-months post-treatment (Wykes 
et al., 2003).  On a broader level of functioning, research has found both, CRT and IPT 
(for a discussion on IPT see below) effective for reducing symptoms of SMI (Medalia, 
Aluma, Tryon, & Meriam, 1998; Medalia, Dorn, & Watras-Gran, 2000; Spaulding et al., 
1999).  
 Cognitive-behavioral therapy (CBT) for psychotic disorders (Fowler, Garety, & 
Kuipers, 1995). Even though CBT has originally been developed as a treatment approach 
for depressive disorders (Beck, Rush, Shaw, & Emery, 1979), it has been modified to 
target a variety of other disorders, including psychotic disorders. As such, CBT for 
psychotic disorders is a structured treatment approach that has been successfully 
implemented with inpatients as well as outpatients (Garety, Fowler, & Kuipers, 2000; 
Gould, Mueser, Bolton, Mays, & Goff, 2001). A number of studies have used a CBT 
approach to aid in the treatment of positive symptoms (Tarrier, Beckett, et al., 1993; 
Tarrier, Sharpe, et al., 1993; Chadwick & Birchwood, 1994; Garety, Kuipers, Fowler, 
Chamberlain, & Dunn, 1994). Findings from these studies indicate that CBT techniques, 
such as challenging underlying beliefs, can help reduce delusions, general 
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symptomatology, and alleviate depressive symptoms.  Although CBT primarily targets 
symptoms (i.e. psychosis), its central tenant is to reduce stress and symptom interference 
with functional outcome; it has been shown that CBT improves patient’s ability to cope 
with stressors and increase adherence to treatment and symptom management 
(Turkington, Dudely, Warman, & Beck, 2006). In addition, Rector and colleagues found 
that CBT, in combination with enriched treatment-as-usual (i.e. including case 
management), lead to a reduction in negative symptoms at a six-month follow-up 
(Rector, Seeman, & Segal, 2003). As such, CBT differs from other treatment approaches 
reviewed here, as it does not directly aim to improve basic cognitive abilities related to 
social functioning. Rather, CBT focuses on identifying and challenging dysfunctional 
thought and belief systems, identifying cognitive biases, encouraging the patient to self-
monitor thoughts and beliefs, and helping the client relate cognitions to mood and 
behavior. However, given the heterogeneity of schizophrenia-spectrum disorders, 
treatment approaches need to be tailored individually to address the specific combination 
of symptoms of the particular patient. The primary and underlying aim in CBT with an 
SMI population is thus the identification of the patient’s vulnerabilities, stressors, and 
response style (Fowler, Garety, Kuipers, 1998). Given the individual variability of 
symptom presentation, CBT treatment ranges in duration of treatment and in frequency of 
individual treatment sessions. Garety and colleagues (2000) describe offering on average 
20 sessions of weekly or biweekly meetings with the therapist. However, the reported 
range of sessions offered to individual clients is from 12 to 30 sessions conducted 
anywhere between six months and one year. Fowler and colleagues (1995) 
conceptualized CBT for psychotic disorders in six components that are intended to be 
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administered in any given order, depending on the patient’s needs. The components are 
as follows: 
(1) Engagement and assessment (e.g. building rapport and developing trust, 
utilizing interviewing strategies to obtain detailed and specific information 
pertaining to patient’ s history, symptoms, etc.) 
(2) Coping strategy work (e.g. identifying and modifying existing coping 
strategies; this may involve homework tasks such as keeping a record of 
symptoms) 
(3) Developing an understanding of the experience of psychosis (e.g. evaluating 
existing delusional beliefs and constructing a new way of making sense of 
beliefs; this includes some psycho-education, which builds on patient’s 
understanding of the disorder) 
(4) Working on delusions and hallucinations (e.g. through explorations of 
misattributions and “jumping to conclusion” biases) 
(5) Addressing mood and negative self-evaluations (e.g. using standard cognitive 
therapy approaches to address low self-esteem, etc.) 
(6) Managing the risk of relapse and social disability (e.g. reviewing learned 
skills and strategies to prevent relapse).  
 Even though the authors state that these six components of CBT treatment can be 
administered flexibly, there appears to be some encouragement to move through the 
components (or stages) in a structured manner as many of the issues addressed during one 
stage build on work done during previous CBT components. However, the authors 
emphasize that, while moving through the treatment components, previous components 
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can be revisited as needed to aid understanding and preserve the therapist-patient 
relationship. Overall, several studies have found CBT to be effective in individuals with 
SMI, reporting that the treatment beneficially impacts positive symptoms, reduces 
relapse, and aids overall recovery during the acute phase of the illness (Gould et al., 
2001; Pilling et al., 2002; Rector & Beck, 2001; Tarrier & Wykes, 2004).  
 Personal therapy for schizophrenia (Hogarty, et al., 1995). Personal Therapy 
(PT) for Schizophrenia is similar in its treatment approach to CBT (described above). As 
with CBT, PT aims to identify and modify stressors while focusing on relapse prevention 
as well as the enhancement of personal and social adjustment for people with SMI. 
However, unlike CBT, PT does not focus directly on positive symptoms or symptom 
remission in general. To that end, PT’s focus is more on preventing relapse in patients 
with chronic SMI who are stable, and less on patients with acute symptoms.  Hogarty and 
colleagues found that for patients with social support (i.e. living with family), PT reduced 
relapse rates (but not for those patients living independently who have received PT); 
similarly, patients who continued to participate in PT over an extended period of time 
(i.e. over one year) showed more positive effects in social adjustment (Hogarty, 
Kornblith, et al., 1997; Hogarty, Greenwald, et al., 1997). The treatment is delivered in 
three phases:  
1. The basic phase introduces the PT approach and is used to establish 
rapport with the client. An individual treatment plan is formulated and 
clients learn about their illness and treatment, including identifying their 
individual signs and symptoms, stressors, and ways of coping.  
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2. The intermediate phase focuses on maintaining and enhancing clinical 
stability, continued psychoeducation (including adjustment to living with 
the disorder), facilitating skill development to resume activities of daily 
living. This phase also introduces relaxation techniques and social skills 
training.  
3. The advanced phase continues to build on previous phases of PT and also 
addresses conflict resolution skills as well as social and vocational issues 
important to recovery.   
Overall, PT can be described as a modified approach to treatment of SMI clients, 
combining psychotherapy, psychoeducation and case management strategies.  
 Functional cognitive-behavioral therapy (fCBT) (Cather, 2005). Functional 
CBT focuses on increased functioning and well-being in people with schizophrenia. Penn 
and colleagues introduce fCBT as “a brief individual treatment for schizophrenia-
spectrum disorders that targets residual symptoms that interfere with functional goal 
attainment, including interpersonal goals” (Penn et al., 2004). Thus, fCBT differs from 
the above-described CBT and PT treatments in that it does not focus as much on relapse 
prevention. In addition, fCBT is intended to be a shorter treatment approach with 16 
weekly sessions and 4 bi-weekly booster sessions. The sessions are broken down into 
steps with different treatment foci as follows: 
(1) Session 1 introduces the fCBT treatment approach to the client and is used to 
build rapport with the client.  
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(2) Sessions 2 through 5 focus on identifying of functional treatment goals and 
barriers to the achievement of goals, as well as on identifying and pursuing 
pleasant activities in order to increase well-being and, overall, quality of life. 
(3)  Sessions 6 through 16 focus on specific treatment modules addressing 
specific deficits or symptoms the individual client is experiencing (e.g. 
negative symptoms, delusions, difficulty with social relationships, 
maladaptive coping strategies) via CBT approaches. However, unlike 
traditional CBT, the authors emphasize an active approach to functional 
improvement (e.g. scheduling activities and engaging in activities).  
Although fCBT has been found to aid with the improvement of positive symptoms, 
particularly auditory hallucinations, no significant improvements were noted in the realm 
of social functioning (Cather et al., 2005).  This is particularly interesting given the stated 
focus of the fCBT treatment approach as one that emphasizes functionality over symptom 
reduction. However, the authors noted that fCBT is a relatively recent treatment approach 
that needs to be further evaluated via empirical studies.  
 Training of affect recognition (TAR) (Wölwer et al., 2005). TAR is a socio-
cognitive treatment approach aimed specifically at the remediation of deficits in facial 
affect recognition in a SMI population. The training is conducted in small groups (two 
participants and one therapist) and can be done with inpatients as well as outpatients. 
However, the authors note that TAR is geared specifically toward less symptomatic and 
more stable participants. TAR consists of a total of 12 sessions. Participants meet with 
their therapist twice a week for 45-minute sessions. The training consists of emotion 
perception exercises, ranging from the identification and discrimination of facial affect to 
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the integration of facial expressions into a social-behavioral context and situational 
context. This treatment approach has been found useful in producing significant 
improvement in affect recognition abilities.  
 Cognitive-behavioral social skills training (CBSST) (McQuaid et al., 2000). 
CBSST was developed with a middle-aged and older adult SMI population in mind. The 
authors describe age-related patient characteristics such as increasing problems with 
physical health, potential loss of support, as well as particular belief systems (i.e. “an old 
dog can’t learn new tricks”) as factors influencing the development of CBSST (McQuaid 
et al., 2000). Further, the authors acknowledge that both CBT and social skills training 
(SST) have been found to include beneficial treatment strategies targeting the specific 
treatment needs of an SMI population. The underling rationale is that CBT techniques 
that have been found useful in the treatment of schizophrenia-spectrum disorder can be 
enhanced for older adults when combined with a social skills training approach, stressing 
repetition and practice of learned techniques and skills. In addition, the authors cite the 
potential stigma toward psychotherapy in an older cohort, reasoning that going to “class” 
may encourage more willingness to engage in treatment. The treatment approach consists 
of self-contained therapy modules that can be arranged and administered in any given 
order. CBSST is geared toward outpatients and usually administered in 12 weekly one-
hour sessions. The two overarching targets of CBSST are improvement in social 
functioning as well as symptom reduction while keeping in mind the increased cognitive 
difficulties faced by an older population. To that end, CBSST focuses on the impact of 
beliefs or cognitions on mood and behavior as well as on the repetitive practice of 
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pragmatic living skills.  The manualized treatment approach consists of the following 
three modules:  
(1) Focus on cognitive-behavior skills (including training in basic cognition-
challenging skills, using these skills to increase treatment adherence, gaining 
increased coping skills and applying them to prevent relapse, and reducing 
conviction regarding psychotic symptoms). 
(2) Focus on symptom self-management (including improving skills in areas of 
problem-solving, identifying symptoms of relapse, and managing warning 
signs). 
(3) Focus on symptom management and coping with persistent symptoms 
(including medication adherence strategies utilizing mnemonic aids and 
environmental structuring, and cognitive and behavioral strategies to identify 
and cope with ongoing symptoms).  
Some of the above named approaches are taken from the UCLA Social and Independent 
Living Skills Series (Psychiatric Rehabilitation Consultants, 1991), especially from the 
Symptoms Management Module. Other approaches and techniques were taken from the 
traditional CBT approach and used in modified ways to address the specific needs of 
older individuals with SMI. A pilot study conducted by the authors showed that CBSST 
is beneficial for participants, especially with regards to treatment engagement and 
adherence.  
 As mentioned above, treatment interventions specifically targeting social 
cognitive dysfunction are mostly administered in a group format. Usually, group sizes 
average about six patients and one or more instructors. The following treatment 
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modalities have been successfully used with people with schizophrenia-spectrum 
disorders.  
 Integrated psychological therapy (IPT) (Brenner et al., 1992). IPT is a well-
validated, manualized treatment intervention developed to improve neurocognitive and 
socio-cognitive abilities as well as social skills in people with schizoprenia (Roder, 
Mueller, Mueser, & Brenner, 2006). The underlying premise that basic neurocognitive 
deficits have cascading effects on higher-level social and interpersonal functioning is 
addressed via different treatment modules that aim to improve necessary cognitive skills 
in order to effectively teach higher-level skills. With this sequential effect in mind, IPT 
modules are intended to be taught in order, starting with the more molecular 
neurocognitive functions and working up to a more molar level of social behavior.  This 
group-based intervention is made up of five treatment modules that target these different 
levels of functioning. The domains are: (1) cognitive differentiation, (2) social 
perception, (3) verbal communication, (4) social skills, and (5) interpersonal problem 
solving. As such, IPT spans abilities and functions related to neurocognition and social 
cognition as well as social competence. Specifically, the domains focus on improving the 
following skills and abilities:  
(1) The cognitive differentiation module addresses neurocognitive abilities such as 
attention, verbal memory, cognitive flexibility, and concept formation. Unlike 
other treatment programs, this IPT subprogram aims to improve functioning in 
these areas via group exercises focusing on strategy learning.  
(2) The social perception module addresses social cognitive abilities such as social 
and emotional perception and emotional expression. This subprogram aims to 
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improve participants’ apprehension and interpretation of social situations via 
group exercises utilizing slides depicting various social situations.  
(3) The verbal communication module aims to bridge underlying functional abilities 
with overt behavioral skills. As such, it focuses on neurocognitive abilities that 
directly impact interpersonal communication skills such as verbal fluency and 
other skills related to executive functioning. The module revolves around the 
basic communication skills of listening, understanding, and responding.  
(4) The social skills module focuses on fostering social competence in participants 
and uses in vivo role-plays as a focal strategy.  
(5) The interpersonal problem-solving module adds group-based problem solving 
exercises and thus utilizes skills learned during prior subprograms.  
 As mentioned above, the IPT subprograms are designed to be administered 
sequentially, but, depending on symptom acuity of participants and targeted skills and 
abilities, only relevant subprograms may be administered. Studies up to date have found 
persistent positive global therapy effects independent from the specific number of 
subprograms administered (Roder et al., 2006).    
 IPT has been implemented in inpatient as well as outpatient settings. However, as 
Roder and colleagues address in their recent meta-analysis of studies that utilized the IPT 
treatment approach, studies done with outpatients were limited in number, but 
nonetheless showed positive effects regarding the amelioration of targeted dysfunctions 
(Roder et al., 2006).  
 Cognitive Enhancement Therapy (CET) (Hogarty & Greenwald, 2006). 
Cognitive Enhancement Therapy combines individual computer-based training of 
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cognitive abilities with group-based social cognition training. Overall, the CET approach 
to treatment is based on the “mastery principle” with participants repetitively working on 
skills until the training goal is achieved. Given the approaches and goals inherent in CET, 
participants benefit most from this treatment approach once their symptoms are in 
remission and stable. Thus, CET targets a stable, non-substance abusing outpatient 
population and is recommended for use with participants with an IQ of 80 or higher 
(Hogarty, Greenwald, & Eack, 2006). CET uses specific components first used in the IPT 
approach and is heavily based on Ben-Yishay’s general stimulation holistic program 
originally developed for use in people with traumatic brain injury (Ben-Yishay et al., 
1985). Further, CET tailors treatment to individual needs based on cognitive style (i.e. 
cognitive impairment is understood via domain associated cognitive deficits that can be 
impoverished, disorganized, or rigid). CET seeks to identify participants’ individual 
cognitive style and tailor training approaches with these specific symptom presentations 
in mind. For example, the training for individuals presenting with an impoverished 
cognitive style, treatment focuses heavily on learning skills related to elaboration and a 
more “gistful” construction of cognitive schemas. Similarly, for participants with a 
disorganized cognitive style, treatment will focus on improvement of attention and 
planning skills. Lastly, CET training with individuals identified as having a rigid 
cognitive style, treatment focuses on generating alternatives and becoming more flexible 
in behavior as well as in cognitions (Hogarty & Flesher, 1999a). Hogarty and Flesher 
(1999b) indicate that at the core of CET lies meta-cognition. The authors stress the 
importance of “gistful” appraisals and automatic processing. As such, the focus is on 
metacognitive abilites and training includes tasks targeting improvement of processing 
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speed, attention, memory, as well as problem solving skills. CET consists of 
approximately 56 social-cognitive group sessions lasting 90 minutes. In addition, 
neurocognitive deficits are approached via approximately 75 one-hour sessions using 
computer exercises. Specifically, the first part of CET is devoted to mastery of tasks 
pertaining to the above-mentioned domains of neurocognitive functioning. While the 
computer-based training occurs in individual session, the second part of CET focuses on 
fostering social cognitive function and social adjustment and occurs in a group setting. 
Throughout CET treatment, each participant also receives individual supportive therapy 
and medication management. Overall, studies have shown that CET results in improved 
neurocogntive functioning and psychosocial adjustment (Eack, Hogarty, Greenwald, 
Hogarty, & Keshavan, 2007; Hogarty et al., 2006; Hogarty et al., 2004). 
Social Cognition and Interaction Training (SCIT) (Penn et al., 2007). SCIT is a 
manual-based treatment approach that has been recently developed to address social 
cognitive dysfunctions in people with schizophrenia-spectrum disorders, especially 
individuals with paranoid symptoms. Specifically, SCIT addresses deficits in emotion 
perception, social perception and social cognitive biases, attributional style, cognitive 
flexibility, social relationships, and theory of mind related skills. SCIT, initially 
developed for use with an inpatient population, is structured as a group-based treatment 
approach consisting of 20 training hour-long sessions with sessions conducted up to three 
times per week. This treatment approach consists of three phases of training: 
(1) Understanding emotions: This module incorporates a “personalized” 
understanding of social cognition (i.e. exploring the concept via personal 
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experiences of participants) and defining basic emotions and relating them to 
facial expressions.  
(2) Exploring social cognitive biases: This module includes exploration of common 
biases held, especially by individuals with paranoid symptoms, and focuses on the 
“jumping to conclusions” phenomena as well as offers alternative strategies to 
avoid the pitfalls ambiguous situations can provide.  
(3) Integrating materials from previous sessions: This final module aims to aid 
participants to apply learned materials and skills into their everyday lives.  
 A pilot study conducted by Penn and colleagues (2005) found that inpatients 
trained with SCIT showed moderate improvement in attributing hostile and aggressive 
intent in others, emotion perception, and showed significant improvement in ToM 
measures (Penn, Roberts, Munt, Silverstein, Jones, & Sheitman, 2005).  Combs and 
colleagues have conducted another study of the efficacy of SCIT in a forensic inpatient 
population and found that individuals improved in all targeted social cognitive domains 
(Combs, Adams, Penn, Roberts, Tiegreen, & Stem, 2007).  
 Social cognition enhancement training (SCET) (Choi & Kwon, 2006). SCET is 
a group-based treatment approach designed for stable, non-substance abusing outpatients 
with SMI. The central tenet of SCET is improvement in social cognitive functioning. The 
focus is on a subset of social cognition, specifically ToM-related skills such as social 
context appraisal and perspective-taking skills. The SCET treatment approach consists of 
a total of 36 90-minute sessions twice per week. The sessions are divided into three 12-
session levels: elementary, middle, and advanced. SCET utilizes four-column cartoons to 
train individuals on social perception, emotion recognition, and social cue perception 
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skills. Tasks include arranging the cartoon in the right order based on contextual 
information. Participants are encouraged to discuss strategies as well as problem-solve 
social situations similar to the ones depicted in the cartoon.  So far, results from SCET 
treatment trials have shown improved performance on a laboratory task assessing for 
abilities related to social context appraisal (Picture Arrangement, WISC-R). SCET is a 
rather recent addition to the social cognition treatment approaches.  
The Future of Social-Cognitive Treatments for SMI Populations 
 Research in the field of social cognition has highlighted the importance of social 
cognitive abilities (e.g. social and emotional perception) in mediating cognitive 
functioning and broader social functioning in the SMI population. As such, functional 
outcome (i.e. social behavior in the treatment milieu and community functioning) has 
been tied not only to symptom reduction and stabilization (e.g. Medalia et al., 1998), but 
also to improved cognition and social cognition (e.g. Penades et al., 2003). For example, 
in a recent review of social cognition and functional outcome, Couture and colleagues 
emphasized evidence for a relationship between social perception and various domains of 
functional outcome (Couture et al., 2006). However, research has devoted less attention 
to the functional significance of other social cognitive domains (i.e. ToM and 
attributional style). Improving functional outcomes in individuals with SMI has been an 
essential tenant in the development for social cognitive treatment approaches, especially 
with regard to their potential to become acknowledged as evidence-based practice. To 
that extent, the above reviewed interventions can be viewed as interventions targeting 
specific domains of social cognition (e.g. SCET) and interventions that target a broader 
range of social cognitive abilities (e.g. IPT and SCIT).  
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 As described above, there are several psychosocial interventions to date that 
explicitly target social cognitive dysfunction in individuals with SMI (e.g. Brenner, 
Hodel, Roder, & Corrigan, 1992; Hogarty & Greenwald, 2006; Penn, Roberts, Combs, & 
Sterne, 2007). The clinical outcome research is rapidly moving toward recognition of 
such interventions as evidence based practice.  However, different interventions address 
different dimensions and domains of social cognition.  Research on both intervention 
development and clinical outcome is increasingly focusing on which specific dimensions 
and domains are actually involved in treatment and recovery processes, which are most 
accessible to treatment, and which are most important with regard to personal and social 
functioning in the real world.  Nevertheless, the scientific priority for outcome data on 
broad, multi-component treatment also remains high.  Both types of research are needed 
now and in the near future.  
 The range and diversity of existing treatment modalities, however, make it 
difficult to determine the logical next steps in research.  Different modalities focus on 
different social cognitive abilities and impairments.  There are striking differences in the 
modalities’ time courses (or “dosage,” to use a pharmacological term).  Although the 
overall research results suggest clinical effectiveness, the outcome expectations and 
measures are too diverse to allow any more specific conclusions. Ultimately, one should 
expect that specific modalities or packages of modalities will be identified as optimally 
effective for specific clinical presentations or constellations of impairments, but this will 
come only after years of clinical trials. Meanwhile, it seems that a reasonable research 
strategy is to study one modality that strikes a balance between focus and 
comprehensiveness, that is, a modality that addresses a moderate range of specific social 
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cognitive impairments whose ecological validity has a reasonable degree of face validity.  
Controlled or partially controlled trials of such a modality will gradually expand the 
database of social cognitive treatment toward future meta-analyses that will consolidate 
confidence that this approach has substantial promise. The values of such trials will be 
enhanced when they are done in a context that allows additional study of the factors that 
enhance or inhibit response to treatment. Similarly, the values of these trials will be 
enhanced when outcome can be measured in terms of specific cognitive changes, as well 
as functional recovery.  
Present Study 
 The purpose of this dissertation project is to further scientific understanding of 
treatment for social cognitive impairment in SMI.  The project includes an empirical 
study of such treatment in the form of a controlled outcome trial.  The choice of treatment 
is based on a comprehensive review and analysis of previous findings on social cognitive 
impairment, its role in personal and social functioning, and its amenability to treatment.  
Specifically, this study aims to demonstrate that deficits in social cognition can be 
ameliorated via a targeted treatment approach such as SCIT. As such, this study is a 
clinical trial of a social cognitive treatment modality in a context that allows for 
systematic evaluation of different outcome domains and possible moderators of the 
treatment effect. The modality chosen for this project is the Social Cognition and 
Interaction Training (SCIT).  Developed by Penn and colleagues, SCIT addresses a range 
of social cognitive domains within an average time frame (a total of 20 training sessions).  
It can be used independently, i.e. is not reliant on additional interventions such as social 
skills training. SCIT has been developed and tested primarily in inpatient settings, with 
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only one preliminary study in community settings published so far (Roberts, Penn, and 
Labate, 2010). We designed the present study to evaluate a targeted treatment for social 
cognition deficits (SCIT) in a severely mentally ill population in real-world settings. As 
such, the heterogeneity of schizophrenia spectrum disorders in community participants as 
well as constraints imposed by the real-world setting calls for a hybrid design rather than 
a conventional controlled trial. In this project, a series of SCIT groups were conducted in 
outpatient settings that serve people with SMI. Clinical and neurocognitive assessment 
data were included to explore the possible role of clinical and neurocognitive factors as 
moderators of the treatment effect. The offered social cognitive treatment approach aims 
to be inclusive of important socio-cognitive domains identified by research thus far. 
Specific social cognitive impairments addressed by SCIT include emotion and social 
perception (including social cues, facial affect recognition), social cognitive biases and 
attributional style (e.g. “jumping to conclusions”), cognitive flexibility, and ToM skills. It 
is hypothesized that individuals participating in SCIT treatment groups will improve in 
the above named domains over the course of SCIT treatment as compared to individuals 
receiving the standard outpatient care regimen. This hypothesized treatment effect was 
measured via the social cognition outcome measures described below. Specifically, it is 
hypothesized that each group will show improved performance on the social cognition 
measures after receiving SCIT treatment. Thus, Group 1 (SCIT then TAU) is expected to 
show improvement on assessment 2, while Group 2 (TAU then SCIT) is expected to 
show improvement on assessment 3 (see Figure 2.1).  
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Figure 2.1 Central hypothesis of the present study.  
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Chapter 3 - Method 
Participants 
 Forty participants with a primary diagnosis of an Axis I psychiatric disorder in the 
schizophrenia spectrum participated in this study. Individuals in outpatient treatment 
settings were enrolled in the study if the met the following inclusion criteria: between 19 
and 64-years of age, current DSM-IV diagnosis of schizophrenia or schizoaffective 
disorder, stable antipsychotic medication regimen, no concurrent substance abuse or 
dependence, no mental retardation, and no organic brain injury or pathology.  
Overall, 42 individuals agreed to participate in the study. Two individuals 
withdrew consent before the study commenced and where excluded from the final study 
sample. The remaining 40 participants were selected into two groups: 1) SCIT – TAU, 
receiving SCIT therapy first and then TAU; and 2) TAU – SCIT, receiving TAU first and 
then participated in SCIT therapy. Randomness in participant selection and group 
assignment was constrained by individual schedules as well as schedules and availability 
of space at treatment sites. Although this prevented truly random sampling and 
assignment, the circumstances allowing participation and driving group assignment were 
themselves sufficiently random to allow the expectation of a reasonably unbiased 
process.  
 Assessments were conducted at three time-points: at baseline (pre-intervention), 
after the first set of SCIT groups were completed (when participants switched from SCIT 
to TAU or TAU to SCIT), and after the second set of SCIT groups was completed (post-
intervention). All 40 participants completed baseline assessments. Of these 40, 36 (10% 
attrition) completed the interventions (18 in the SCIT – TAU group; 18 in the TAU – 
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SCIT group). Of these, 31 participants agreed to complete the second assessment phase; 
and 26 completed the third and last assessment phase. Thus, all participants took part in 
baseline testing, with an attrition rate of 22.5% and 35% for the following assessment 
phases respectively.  
Treatment Settings and Population Sample 
 Participants for this treatment approach were recruited from community-based 
care settings in Lincoln, NE. The settings served as hosts and performance sites for the 
assessment and therapy activities of the study. They were chosen as representative for 
serving people with especially severe and disabling mental illness but functioning outside 
an institutional setting.  The settings also generally operate within a biopsychosocial 
understanding of mental illness guided by principles of rehabilitation and recovery.  This 
creates a climate in which introductions of new skill training and therapy modalities are 
normal and routine occurrences. A close working relationship between the UNL 
psychology department, the Community Mental Health Center of Lancaster County, and 
OUR Homes, Inc. made it possible to conduct the study with minimal disruption to 
ongoing services.  The assessment activities and therapy sessions were integrated into the 
normal operations of the host programs in an effort to make the study activities a natural 
part of the setting.  In collaboration with the study PI, the SCIT therapists composed 
progress notes for each participant, according to agency conventions for group therapy.  
These were entered into the respective participants’ clinical records. 
 The recruiting pool created by the performance sites is expected to be highly 
heterogeneous with respect to any demographic and clinical measures commonly used in 
psychiatric research, except for diagnosis and occupational functioning.  Diagnoses are 
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overwhelmingly in the schizophrenia spectrum.  Almost by definition, people in 
psychiatric day programs have significant difficulties in occupational functioning.  The 
interaction of diagnostic and functional factors can be presumed to create a recruiting 
pool reasonably representative of people in the lower middle third of the distribution of 
global functioning, e.g. as measured by Axis V of the DSM.  This is compatible with 
expectations of who stands to benefit from SCIT. 
 Midtown Center  
The Midtown Center is an adult day rehabilitation program for individuals with 
SMI. Approximately 50 individuals attend the program daily (Monday-Friday) and are 
encouraged to take an active role in their rehabilitation through participation in the day-
to-day program operation (e.g. lunch preparation, answering phones, publishing daily and 
monthly newsletters, etc.). Midtown Center is administered by the Community Mental 
Health Center of Lancaster County.   
 Southville Center  
The Southville Center is a day rehabilitation program for adults with SMI. The 
program encourages “healthy living” and, to that extent, offers individuals exercise 
classes and well-balanced food-choices. Further, Southville Center offers tutors and 
classes, helping individuals work on achieving personal goals (e.g. obtaining a GED). A 
maximum of 120 individuals attend Southville Center on a daily (Monday-Friday) basis. 
The Southville Center is administered by OUR HOMES assisted living facilities.  
Treatment Conditions  
 This research project examines the efficacy of a social cognitive treatment 
intervention, Social Cognition and Interaction Training (SCIT) developed by Penn and 
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colleagues at the University of North Carolina-Chapel Hill (UNC). The SMI research lab 
at UNL has had close ties with the UNC research group lead by David Penn over several 
years. Of the existing social cognitively oriented treatment approaches, SCIT was chosen 
as it was recently developed and appears to target an essential range of social cognitive 
domains and promises to ameliorate functional impairment in an SMI population. As 
such, this research will compare a manual-based treatment approach (SCIT) to treatment-
as-usual (TAU) as offered in targeted treatment settings. TAU in identified treatment 
settings usually consists of case management (including medication management), plus 
various occupational, rehabilitative and supportive services, especially for the population 
segment sampled in this study.  
Measures  
 Demographic information. Demographic information will be collected form 
participants regarding age, gender, race, psychiatric diagnosis, highest education level 
completed, current living situation, and currently received treatments and/or services and 
treatment and/or service providers. In addition, all participants will be assessed using the 
following clinical, neurocogntive, and social cogntive measures.  
Clinical measures and neurocognitive measures. 
 Brief Psychiatric Rating Scale (BPRS; Ventura et al., 1993). This semi-
structured interview provides an efficient and quick way to assess symptom change in 
persons with severe mental illness. It consists of 24-items of which 14 are interview-
based and 10 are based on observed behavior and/or speech during the interview. The 
administration manual for the BPRS provides interview questions, symptom definitions 
and specific anchor points for rating symptoms. Ratings are based on severity as well as 
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frequency of experienced symptoms and range from 1 (not present) to 7 (extremely 
severe). Thus, the total score on the BPRS can range from 24 to 168, with higher scores 
indicating more severe and frequent psychopathology. The BPRS is one of the most 
widely used measures in psychiatric outcome studies as well as clinical 
psychopharmacology research. Studies supported the BPRS as a well-validated and 
reliable assessment measure and found it to consist of four core factors, which underlie 
the structure of the BRPS. The factors are anxiety/depression (including BPRS items 
somatic concern, anxiety, depression, suicidality, and guilt), thinking disorder (including 
BPRS items of grandiosity, hallucinations, unusual thought content, bizarre behavior, and 
conceptual disorganization), withdrawal (including BPRS items disorientation, blunted 
affect, emotional withdrawal, elevated mood, self-neglect, and motor retardation), and 
activity (including BPRS items tension, excitement, motor hyperactivity, distractability, 
and mannerisms and posturing) (Burger, Calsyn, Morse, Klinkenberg, & Trusty, 1997; 
Thomas, Donnell, & Young, 2004; Velligan et al., 2005).  
 Neuropsychological Assessment Battery – Screening Module (NAB-Scr; Stern 
& White, 2003). The NAB-Screener is a recently developed neuropsychological 
assessment to evaluate cognitive functioning in adults aged 18 to 97. The modular 
assessment battery consists of subtests that target critical domains of cognitive 
functioning, including attention, language, memory, spatial, and executive functions. The 
evaluation also provides an overall or total screening index indicating the level of overall 
cognitive functioning. Given the recent development of the NAB, studies evaluating its 
psychometric properties are very limited at this time. However, two reviews published in 
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the Mental Measurements Yearbook indicate that the NAB is based on extensive 
normative and validation data (Makatura, 2005; Van Gorp & Hassenstab, 2005).  
Trail Making Test - Trails A and B (Reitan & Davidson, 1974). The original 
Trail Making Test was developed in 1944 as part of the Army Individual Test Battery and 
now is a standard component of the Halstead-Reitan Neuropsychological Test Battery 
(Reitan & Wolfson, 1995). The Trail Making Test is a paper-and-pencil measure of 
visual processing and visuo-motor tracking (Lezak, 1995) and is used to measure 
capacity for organization and sequencing. Trails A requires the participant to connect 25 
numbered dots that are randomly spread across a sheet of paper in sequence during a 
timed administration (i.e. number 1 through number 25). Trails B is more demanding, as 
it requires the participant to connect a series of 25 randomly distributed dots on a sheet of 
paper containing numbers and letter in an alternating sequence (1-A-2-B-3-C etc.) during 
a timed administration. Participants are stopped and alerted to errors in sequencing, 
requiring them to go back to the last correct stop and redirect their sequencing to correct 
their performance. Scores for both Trails A and B are based on the time an individual 
needs to correctly complete each task.  Efficient performance on the Trail Making Test, 
especially Trails B, depends in part of facets of working memory and sufficient cognitive 
flexibility.  
Controlled verbal fluency task (FAS; Borkowski, Benton, & Spreen, 1967). A 
test of verbal fluency; participants are given a total of three letters, one letter at a time (F, 
A, and S) and have 60 seconds to responds with as many words as possible that start with 
the given letter. Proper nouns were scored as incorrect; total number of correct words 
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generated within the allotted 60 seconds for each of the three trials is added up and used 
as the final score.  
Letter-Number Sequencing (LNS; WAIS-III; Wechsler, 1997). The LNS subtest 
of the WAIS tests participants’ attention and working memory by reading a sequence of  
intermixed letters and numbers (e.g. Q-1-B-3-J-2) to them at a rate of 1 per second, which 
they have to repeat back to the examiner after manipulating the order and place the 
numbers in ascending numerical order and then the letters in alphabetical order.  The 
letter-number sequences become increasingly longer and range from 2 stimuli (e.g. A-3) 
to a maximum of 8 stimuli. A total of three trials are presented at each length with the test 
being discontinued after the participant fails three consecutive trials of the same length. 
Each correctly manipulated sequence receives a score of 1, for a maximum score of 21.  
Social cognition measures. 
Hinting Task (Corcoran, Mercer, & Frith, 1995). The Hinting Task is a theory 
of mind (ToM) measure administered as part of a social cognition assessment battery. 
ToM is of particular interest in understanding the relationship between cognition and 
social interactions and refers to the ability to infer the intentions and beliefs of others.  It 
has been found that persons with schizophrenia have difficulty utilizing inductive 
reasoning to infer the attitudes and intentions of others (Frith, 1992). Additionally, ToM 
deficits appear to be unique to persons diagnosed with schizophrenia (Janssen, 
Krabbendam, Jolles, & van Os, 2003). In fact, Corcoran (2003) found that persons with 
schizophrenia rely on a different strategy to understand the meaning behind pragmatic 
language compared to a non-clinical population. The Hinting Task consists of ten short 
vignettes involving two people and asks the participant to infer the intention behind 
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veiled speech acts. Each vignette ends with one of the characters saying something to the 
other. After each vignette is presented, participants are asked a question regarding the 
characters intention (e.g. “What does George really mean when he says this?” or “What 
does Paul want Jane to do?”). Each vignette is read out to participants and available for 
participants to read through as many times as necessary. If participants cannot make an 
inference or arrive at an inappropriate solution, more detail is added to the interaction 
giving a more obvious hint regarding the underlying meaning to the participants. Scores 
range from 0 to 2 per vignette (for a total score range of 0 to 20) with lower scores 
indicative of a more concrete understanding of the vignette and higher score indicative of 
a better understanding of underlying intentions of the characters in the depicted 
interaction.  Although there is limited psychometric data available, the Hinting Task is 
sensitive to deficits in schizophrenia, correlates with other ToM measures and has good 
face validity in studies with seriously mentally ill participants (Corcoran et al., 1995; 
Corcoran & Frith, 2003; Yager & Ehmann, 2006).  
Social Perception Scale (Garcia, Fuentes, Ruiz, Gallach, & Roder, 2003). 
Garcia and colleagues (2003) developed the Social Perception Scale in order to assess the 
following criteria: stimuli identification, interpretation of images, and title assignment. 
This measure consists of four photographs that are presented to participants. Two of the 
pictures were chosen because of their cognitive complexity and the other two because of 
their emotional content. Participants are presented with one photograph at a time and 
asked to carefully look at the picture. Participants are told that the same set of questions 
will be asked for all four pictures and are asked to limit their answers to what appears in 
the picture and to not make any assumptions. Questions asked are: 1) Could you tell me 
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what details/elements/things you can actually see in this photo? 2) Could you tell me 
what is happening in this photo, keeping in what you told me before? 3) What title would 
you give to this photo? In a few words, mention the key elements of the picture. 
Participants are evaluated on the basis of whether they were able to address the three key 
concepts of the photograph: situational context, actor/s and action or interaction amongst 
them. One point is given for each aspect mentioned, points are added up to comprise a 
total score indicating the number of correctly identified details. It should be noted that the 
Social Perception Scale does not measure social functioning or social skills, rather it aims 
to measure cognitive abilities necessary in social perception. Given the relative recent 
development of this measure, studies to determine psychometric features have yet to be 
undertaken. Although its use so far has been limited, studies using the Social Perception 
Scale found effective in measuring cognitive abilities necessary for intact social 
perception (Combs, Adams, et al., 2007; Fuentes, Garcia, Ruiz, Soler, & Roder, 2007; 
Ruiz, Garcia, Fuentes, Garcia-Merita, 2005). Even though the Social Perception Scale has 
very limited psychometic data available, it was chosen as an outcome measure because 
social perception is a social cognitive construct specifically addressed by the SCIT 
treatment module.  
Ambiguous Intentions Hostility Questionnaire (AIHQ; Combs, Penn, Wicher, 
& Waldheter, 2007). The AIHQ is a new measure specifically targeting social cognitive 
bias (hostility) in schizophrenia-spectrum disorders. It consists of 15 short vignettes 
reflecting negative outcomes that vary in intentionality (i.e. intentional, accidental, and 
ambiguous intentions). In a preliminary study to evaluate the psychometric properties of 
the AIHQ, the authors reported supportive findings regarding the validity and reliability 
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of the measure. However, this study was conducted with a non-clinical sample and did 
not address test-retest reliability. Other preliminary findings indicate that the AIHQ is 
predictive of violence and aggression in an inpatient sample of people with schizophrenia 
(Waldheter, Jones, Johnson, & Penn, 2005). Most importantly, the AIHQ has been found 
to be a sensitive outcome measure in a SCIT treatment trial in inpatients with 
schizophrenia (Penn et al., 2005).  
Need for Closure Scale (NFCS; Webster & Kruglanski, 1994). The NFCS is 
used to assess the extent to which a person, faced with a decision or judgment, desires 
any answer (as compared with confusion and ambiguity). The authors derive the need for 
cognitive closure from two general tendencies: urgency and permanence. The urgency 
tendency refers to the inclination to attain closure immediately and to seize any early 
information that can potentially lead to closure. The permanence tendency refers to the 
inclination to maintain closure for as long as possible and to stick with information 
leading to the achieved closure.  The NFCS is a 16-item Likert-type scale designed to 
assess attitudes, beliefs, and experiences related to the tolerance of ambiguity with higher 
scores indicating a greater need for closure.  
 Emotional Context Perception Task (ECPT; Choi, Liu, Kleinlein, Wynne, 
Spaulding, 2006). The ECPT is a computerized task assessing the perception and 
recognition of emotional cues. It consists of 40 cartoon portrayals depicting a cartoon 
character expressing one of nine emotions (fear, disgust, contempt, shame, anger, 
surprise, sadness, happiness, and neutral). This character is depicted either in a group of 
people who also express an emotion or alone (blank background). The 40 stimuli include 
8 portrayals without contextual emotions (blank background) and 32 portrayals with 
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contextual emotions (“main character” in a group of people). Participants are asked to 
identify the emotion by answering a multiple-choice question and to rate the intensity of 
the identified emotion on a 7-point Likert scale.  
Social Functioning Scale (SFS; Birchwood, Smith, Cochrane, Wetton, & 
Copestacke, 1990). The SFS is a 79-item scale designed to assess functioning in 
individuals with schizophrenia-spectrum disorders. It targets the level of ability in seven 
areas: 1) social engagement (e.g. “how much time do you spend alone?”), 2) 
interpersonal communication (e.g. “how many friends do you have?”), 3) activities of 
daily living (e.g. “how often do you prepare and cook a meal?”), 4) recreation (e.g. “how 
often do you play a sport?”), 5) social activities (e.g. “how often do you visit friends?”), 
6) competence at daily living (e.g. “how able are you to handle your own money?”), and 
7) occupation/employment (e.g. “are you in regular employment?”). Although the 
questionnaire can be filled out by the participant, typically the examiner will ask the 
questions and fill out the form. This scale has been shown to be a reliable, valid, and 
sensitive measure of social functioning (Birchwood et al., 1990).  
 Attributional Style Questionnaire (ASQ; Peterson, Semmel, von Baeyer, 
Abramson, Metalsky, & Seligman, 1982).  The ASQ is a questionnaire consisting of 48 
Likert style items designed to measure the causal attributions offered by patients 
regarding good or bad events in their lives. The attributional dimensions assessed with 
this instrument include internal-external, stable-unstable, and global-specific. Each item 
is measured on these dimensions via separate 7-point Likert scales. This measure has 
been found to be a valid and realible assessment of people’s attributional style (Seligman, 
1991; Sweeney, Anderson, & Bailey, 1986).  
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Multnomah Community Ability Scale (MCAS; Barker et al., 1994). The MCAS 
is a 17-item Likert-type scale specifically designed to assess level of functioning in 
individuals with SMI. The scale is completed by the individual’s community support 
worker or case manager and includes four subscales (interference with functioning, 
adjustment to living, social competence, and behavioral problems) and an overall (total) 
score of functioning. Good test-retest reliability and internal consistency haven been 
reported (Barker et al., 1994).  
 Emotional Context Perception Task (ECPT; Choi, Liu, Kleinlein, Wynne, 
Spaulding, 2006). The ECPT is a computerized task assessing the perception and 
recognition of emotional cues. It consists of 40 cartoon portrayals depicting a cartoon 
character expressing one of nine emotions (fear, disgust, contempt, shame, anger, 
surprise, sadness, happiness, and neutral). This character is depicted either in a group of 
people who also express an emotion or alone (blank background). The 40 stimuli include 
8 portrayals without contextual emotions (blank background) and 32 portrayals with 
contextual emotions (“main character” in a group of people). Participants are asked to 
identify the emotion by answering a multiple-choice question and  rate the intensity of the 
identified emotion on a 7-point Likert scale.  
Face Emotion Identification Task (FEIT; Kerr and Neale, 1993). The FEIT 
utilizes black and white still photographs of facial emotions developed by Ekman and 
Friesen (1976) and Izard (1971). It was administered in the computerized version 
consisting of 19 black and white still photographs presented for approximately 15 
seconds each, with an interval of 10 seconds between photographs. During the interval, 
the participants were asked to pick one of six basic emotions (i.e. happy, sad, angry, 
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surprised, afraid, and ashamed) that best describes the face in the previous photograph, 
Each emotion corresponded to a number (1-6) on the screen and participants pressed the 
corresponding key on the keyboard to finalize their answer and move on the next 
photograph. The total number of correct answers was used as the final score for this task.  
Voice Emotion Identification Task (VEIT; Kerr and Neale, 1993). The VEIT 
was administered in the computerized version consisting of 21 audio recordings of 
verbally presented statements with neutral content (e.g. “He tossed the bread to the 
pigons”, “Fish can jump out of the water”). Participants were asked to rate the voice tone 
that best describes each statement and chose their answer from a list of six basic emotions 
(i.e. happy, sad, angry, surprised, afraid, and ashamed). As with the FEIT, each emotion 
was listed with a corresponding number (1-6) that participants used to record their answer 
via the corresponding keyboard key. The total number of correctly identified items was 
used for the final score of this task.  
Benton Facial Recognition Test (BTFR; Benton, Hamsher, Varney, & Spreen, 
1983). The BFRT consists of a series of sheets containing photographs of physically 
similar faces (i.e. not showing hair or glasses). Participants are presented with a sheet 
containing a single “target” face and are asked to match the target to a set of six face 
photographs for a total of 22 trials. The first six trials consist of participants selecting one 
matching face photograph; the remaining trials ask participants to identify three correct 
matches from a total of six face photographs presented in different angles (i.e. the face 
changed in orientation or lighting conditions compared to the target photograph).  
Bell Lysaker Emotion Recognition Task (BLERT; Bell, Bryson, & Lysaker, 
1997). The BLERT is an affect perception task and was administered in its computerized 
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version consisting of 21 short video clips. In each clip, an actor reads one of three neutral 
scripts, while displaying one of seven basic emotions (i.e. happy, sad, angry, afraid, 
surprised, ashamed, and neutral). After each clip, participants are asked to pick the 
emotion that best describes the actor in the video from a list of seven emotion. As with 
the FEIT and VEIT, each answer choice on the computer screen corresponds with a 
number on the keyboard that is used by participants to make their answer choice. The 
total number of correctly identified emotions is used as the final score on this task.  
Design and Procedure 
 Power analysis. Using the standard power level of .80, the expected n for this 
study is 20 subjects per group (overall N=40). Effect sizes from previous studies by Penn 
and colleagues (2005; 2007) and Combs, Adams, and colleagues (2007) on the AIHQ 
ranged from r = .50 to r = .82 and specific sample sizes ranged from N=6 to N=28. A 
reasonable attrition rate, considering all the subjects are in long-term rehabilitation 
programs before this study even begins, is 10%.  The remaining 36-subject sample is well 
within the sample sizes used by Penn and colleagues as well as Combs and colleagues in 
initial demonstrations of effectiveness of this modality (Penn, et al., 2005; Penn, et al., 
2007; Combs, Adams, et al., 2007).  
 Participant recruitment. Staff in treatment settings as well as the primary 
investigator checked available medical records to determine if participants meet the 
inclusion criteria. Once the participants were identified, they were approached by staff 
(incl. the primary investigator) and given information about the study and the opportunity 
to enroll. After informed consent was obtained and HIPPA rules explained, the 
participants were selected into either one of two treatment groups: 1) first receiving SCIT 
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and then TAU, or 2) first receiving TAU and then SCIT. Participants were selected rather 
than randomly assigned into treatment groups in order to maximize comparability 
between SCIT and TAU groups in terms of participant characteristics (e.g. age, gender). 
All participants, regardless of treatment group, completed both phases of the study and as 
such participate in SCIT treatment groups as well as the control (TAU) group, differing 
only in the sequence in which the phases were completed. This study enrolled a total 20 
participants in each treatment condition for a combined total of 40 participants. Previous 
pilot studies conducted by Penn and colleagues and an inpatient trial conducted by 
Combs and colleagues obtained significant study results with smaller samples (N=17 and 
N=18) (Penn, et al., 2007; Combs, Adams, et al., 2007).  
 Experimental design and treatment conditions. This study is based on a 
hybrid, quasi-exprimental, rather than a conventional experimental design due to 
restrictions imposed by the real-world setting of this study, including the heterogeneity of 
schizophrenia spectrum disorders in community participants and working with individual 
schedules as well as accommodating time and space restrictions at each treatment site. 
The present study consist of two treatment phases. Thus, Phase I (with post-treatment 
assessment) would in itself be a complete controlled trial under conventional research 
conditions. We hope that, given the inherent limitations of this study, Phase II will 
compensate for the small sample and other limitations that would otherwise compromise 
a purely Phase I design. The treatment conditions included in this empirical analysis 
include a social cognitive treatment modality (SCIT) and treatment-as-usual (TAU). 
Hence, the design of the study is a 2 (Treatment: SCIT vs. TAU) X 3 (Time of 
assessment: pre-treatment vs. between treatment vs. post-treatment) mixed group 
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factorial design. Thirty-six participants (out of the 40 enrolled participants) completed 
both treatment conditions (phases), SCIT and TAU, differing only in the order in which 
SCIT and TAU are received. Group 1 received SCIT, followed by TAU; Group 2 
received TAU, followed by SCIT. SCIT treatment groups and control (TAU) groups each 
consisted of six to eight participants. The primary investigator as well as a co-leader led 
all groups. A total of 20 bi-weekly one-hour treatment sessions were conducted in 
community-based psychiatric care settings. The SCIT was provided according to the 
treatment manual developed by Penn and colleagues (Roberts, Penn, and Combs, 2007). 
Three treatment groups were conducted in each of two study phases, yielding 18 subjects 
in the first group (SCIT first) and 18 subjects in the second group (TAU first): 
 
                                                   Phase 1                 Phase 2 
 
 
 
                       Group 1 
   (N=18) 
                        
                         
                       Group 2 
    (N=18) 
Figure 3.1 Study design: Treatment groups.  
 
Participants in the control group (TAU) continued to receive their individual standard 
care regimen typically consisting of medication management, case management and a 
range of occupational, rehabilitational and supportive services. No alternative, added 
treatment was offered. Participants in both groups participated in pre-, between- and post-
treatment assessments: 
 
SCIT  n=6 
SCIT  n=6 
SCIT  n=6 
 
 
 
TAU 
 
 
 
TAU 
 
 
SCIT  n=6 
SCIT  n=6 
SCIT  n=6 
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                                                 Phase 1                                 Phase 2 
 
 
  Group 1 
   (N=18) 
 
                        
                         
  Group 2 
    (N=18) 
 
Figure 3.2 Study design: Treatment groups and testing phases. 
 
Participants received $5 for their participation after completion of each assessment phase 
for a total of $15 at the end of the study.  
 Treatment fidelity. Two group leaders who are involved in this project as 
graduate level research assistants were assigned per treatment group. Dennis Combs, 
Ph.D., who has worked with SCIT and participated during various stages of the 
development of SCIT, has provided an all-day training workshop for the application of 
SCIT on June 3, 2008. All group leaders involved in this project participated in all parts 
of this workshop and were trained by Dennis Combs, Ph.D. on the application of SCIT 
and running treatment groups using the SCIT manual.  In addition, mock treatment 
groups were used to train group leaders in the application of SCIT and the adherence to 
the SCIT treatment manual. All research assistants were either graduate students in the 
Clinical Psychology Training Program and members of the Serious Mental Illness 
research laboratory at UNL (E. Cook, B.A., C. Davidson, B.A., M. Tarasenko, B.A., A. 
Collins, M.A., L.F. Reddy, B.A., A Wynne, B.A., K.H. Choi, M.A.) or have been 
involved as research assistants with the SMI research group at the Lincoln Regional 
Center. Graduate students were involved in the assessment as well as function as SCIT 
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group leaders in this study; other research assistants were only involved in the assessment 
phases of this study. All research assistants involved in the data collection part of this 
study had prior experience with administration of the measures used in this study.  
 Data analysis. 
Data preparation. Confidentiality of participants was protected and all identifying 
information removed from data materials. All participants were assigned a subject ID 
number (in lieu of name, date of birth, chart numbers, etc.) to represent them in the 
database. Once all the data was coded this way, it was entered into SPSS (SPSS, Inc., 
2006) by the primary investigator. Univariate analyses were used to investigate any data 
entry errors, values beyond the defined range of data coding options, missing values, 
skewness, and kurtosis. Both univariate and bivariate analyses were used to examine 
outliers. Data entry errors, out-of-range values, and missing values were rechecked in the 
original participant files. These values were then corrected or left blank in the instance of 
missing information. Outliers were either be trimmed or transformed, depending on the 
individual case and the outlier’s effects.  
Statistical analysis. Preliminary data analysis uses analysis of variance (ANOVA) 
and χ2 tests to compare demographic background and clinical presentation pre-treatment 
to ascertain that the two groups are initially equivalent and to obtain descriptive sample 
information. Gender was used as a covariate in all subsequent analyses of social cognitive 
outcome variables (see Figure 4 for group composition by gender). The central 
hypothesis (SCIT treatment improves performance on social cognitive outcome 
measures) was explored via 21 ANCOVAs conducted on the social cognitive outcome 
measures (dependent variables) to compare Group 1 (SCIT then TAU) to Group 2 (TAU 
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then SCIT) (independent variables)  in order to establish a treatment effect of SCIT on 
social cognitive functioning. Specifically, ANCOVAs are used to determine differential 
change over time between the two groups. Mean differences are used to qualitatively 
interpret quantitative interaction terms.  
 
 
Figure 3.3. Gender distribution: Number of women and men per group.  
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Chapter 4 - Results 
Demographic and Clinical Characteristics  
 Table 4.1 summarizes the demographic and baseline clinical characteristics of the 
treatment groups (Group 1 = SCIT then TAU; Group 2 = TAU then SCIT). ANOVA and 
χ2 tests revealed no significant differences between groups with regards to participants’ 
education (years of completed education), age, diagnosis, treatment site and current 
symptomatology at baseline.  However, the groups differed significantly in gender 
makeup (χ2 = 4.8, p = .028). The potential impact of this difference on study hypotheses 
was probed. Within the full sample, bivariate correlations between gender and baseline 
social cognitive performance was significant for the BTFR (r = -.336, p = .034) and 
AIHQ Aggression (r = -.363, p = .021), indicating that men scored significantly higher on 
these measures (BTFR between group t(38) = 2.20, p = .03; AIHQ Aggression between 
group t(38) – 2.40, p = .02). Higher scores on the BTFR indicate more correctly 
identified facial expressions; a higher score on the AIHQ Aggression scale indicates a 
more aggressive response to ambiguous situations. Gender was used as a covariate in 
order to address these baseline differences in subsequent analyses of the social cognitive 
data.  
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Table 4.1 
 
Demographic and Clinical Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
* Gender: χ2 = 4.8, p = .028 
  
SCIT-TAU  
   (n = 20) 
 
 
TAU-SCIT 
  (n = 20) 
 
   
Total 
(n = 40) 
 
  
M (SD) or  
M (%) 
 
 
M (SD) or   
M (%) 
 
 
M (SD) or  
 M (%) 
 
 
Age  
(range: 21 – 61 years) 
 
Gender (%) * 
     Female  
     Male  
 
Years of Education 
 
Ethnicity (%) 
    Caucasian 
     Hispanic 
 
Diagnosis – Axis I (%) 
    Schizophrenia, 
Paranoid Type 
    Schizophrenia, 
Undiff Type 
    Schizoaffective 
Disorder 
 
Diagnosis – Axis II (%) 
     None 
     BPD 
     Paranoid PD 
     Avoidant PD 
     Other 
 
Treatment Site 
     Midtown Center 
    Southville Center 
 
37.10 (10.60) 
 
 
 
8 (20%) 
12 (30%) 
 
11.85 (2.13) 
 
 
19 (47.5%) 
1 (2.5%) 
 
 
5 (12.5%) 
 
5 (12.5%) 
 
10 (25%) 
 
 
 
17 (42.5%) 
1 (2.5%) 
1 (2.5%) 
0 (0%) 
1 (2.5%) 
 
 
12 (30%) 
8 (20%) 
 
44.25 (14.04) 
 
 
 
2 (5%) 
18 (45%) 
 
12.68 (2.32) 
 
 
20 (50%) 
0 (0%) 
 
 
5 (12.5%) 
 
8  (20%) 
 
7 (17.5%) 
 
 
 
18 (45%) 
0 (0%) 
0 (0%) 
1 (2.5%) 
1 (2.5%) 
 
 
8 (20%) 
12 (30%) 
 
40.68 (12.80) 
 
 
 
10 (25%) 
30 (75%) 
 
12.26 (2.24) 
 
 
39 (97.5%) 
1 (2.5%) 
 
 
10 (25%)    
 
13 (32.5%) 
 
17 (42.5%) 
 
 
 
35 (87.5%) 
1 (2.5%) 
1 (2.5%) 
1 (2.5%) 
2 (5.0%) 
 
 
20 (50%) 
20 (50%) 
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Table 4.2 summarizes symptomatology and neurocognitive characteristics for all 
study participants at baseline (time 1 testing). ANCOVAs indicated that the two groups 
did not differ on measures of symptoms and neurocognition at baseline; neither did 
performance on these measures differ between treatment sites.  
 
Table 4.2 
 
Baseline (Testing Time 1) Symtomatology and Neurocognitive Characteristics 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
SCIT-TAU  
   (n = 20) 
 
 
TAU-SCIT 
  (n = 20) 
 
   
Total 
(n = 40) 
 
  
M (SD) 
 
M (SD) 
 
M (SD) 
 
BPRS Total 
   Factors: 
   Thought Disorder 
   Anergia 
   Affect 
   Disorganization 
 
Trails A 
Trails B 
     
FAS 
 
Letter-Number 
    Sequencing 
     
NAB Screening  
     Total 
         
 
38.20 (9.89) 
 
3.77 (2.05) 
2.54 (1.05) 
5.84 (2.50) 
3.11 (1.37) 
 
44.65 (29.82) 
144.45 (127.41) 
 
27.80 (11.12) 
 
8.10 (3.45) 
 
 
437.85 (76.51) 
 
41.45 (7.67) 
 
4.21 (2.27) 
3.05 (1.49) 
6.60 (2.51) 
3.26 (1.12) 
 
48.40 (36.29) 
134.75 (89.78) 
 
30.20 (14.13) 
 
7.65 (3.98) 
 
 
442.55 (78.27) 
 
39.83 (8.89) 
 
3.99 (2.15) 
2.80 (1.30) 
6.22 (2.50) 
3.19 (1.24) 
 
 46.53 (32.95) 
139.60 (108.90) 
 
29.00 (12.61) 
 
7.88 (3.68) 
 
 
440.20 (76.43) 
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Treatment Findings 
 The effects of SCIT on social cognition were analyzed in a series of 2 (group: Group 1 SCIT then TAU versus Group 2 
TAU then SCIT) X 3 (time: pretest versus posttest 1 versus posttest2) mixed model analyses of covariance (ANCOVAs) 
(Table 4.3 shows the means for each condition of the design). Gender was used as a covariate in all analyses of outcome 
measures. Of the 21 conducted ANCOVAs, two yielded a significant time x group interaction effect (FEIT and MCAS 
Health), three yielded trend-level significant time x group interaction effects (BTFR, SPS Identified Stimuli, and SPS Title);  
 
Table 3 
Performance on Social Cognition and Social Functioning Measures (adjusted with gender as covariate) 
 Testing Time 1 Testing Time 2 Testing Time 3 
 SCIT-TAU 
 
TAU-SCIT 
 
SCIT-TAU 
 
TAU-SCIT 
 
 
SCIT-TAU 
 
 
TAU-SCIT 
 
 
 
   M (SD) 
 
    M (SD) 
 
         M (SD) 
 
       M (SD) 
 
      M (SD) 
 
     M (SD) 
FEIT Total* 
 
VEIT Total 
 
BLERT Total 
 
BTFR Total ** 
 
ECPT Total*** 
 
11.17 (1.64) 
 
10.58 (2.68) 
 
11.75 (3.57) 
 
39.33 (4.64) 
 
8.42 (2.43) 
 
11.36 (4.22) 
 
9.00 (3.26) 
 
11.29 (5.29) 
 
41.71 (6.33) 
 
6.93 (3.15) 
 
11.92 (3.15) 
 
11.17 (3.21) 
 
12.42 (3.50) 
 
40.00 (5.03) 
 
8.17 (2.12) 
 
10.36 (3.34) 
 
8.79 (3.04) 
 
11.50 (4.62) 
 
40.93 (6.37) 
 
5.43 (2.28) 
 
10.92 (1.78) 
 
10.08 (3.45) 
 
12.67 (5.07) 
 
41.08 (6.37) 
 
8.08 (3.99) 
 
12.57 (3.84) 
 
9.14 (3.28) 
 
11.93 (4.86) 
 
41.21 (6.58) 
 
5.29 (2.81) 
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n (SCIT) = 12; n (TAU) = 14 
SPS 
    Identified   
  Stimuli+    
Interpretations 
    Title ++ 
 
Hinting Task Total  
 
NFCS Total 
 
ASQ Total  
 
 
AIHQ  
    Blame  
    Hostility  
    Aggression ~ 
 
MCAS  
    Total± 
     Health±± 
     Adaptation 
     Social Skills±±± 
     Behavior 
     
SFS 
     Social     
   Engagement 
     Interpersonal   
   Communication 
          
 
38.75 (12.07) 
 
7.75 (2.01) 
3.67 (1.92) 
 
15.25 (4.77) 
 
50.50 (9.35) 
 
2.67 (2.90) 
 
 
 
3.20 (1.00) 
2.18 (.78) 
1.95 (.34) 
 
 
65.08 (11.85) 
20.00 (3.81) 
10.50 (3.23) 
17.25 (4.18) 
17.33 (2.19) 
 
 
11.67 (1.72) 
 
7.83 (1.47) 
 
32.93 (10.28) 
 
8.08 (2.09) 
3.93 (1.82) 
 
15.71 (3.63) 
 
54.93 (11.25) 
 
1.71 (2.76) 
 
 
 
3.04 (.62) 
2.10 (.73) 
2.07 (.39) 
 
 
65.07 (10.56) 
19.07 (3.29) 
10.00 (2.39) 
18.50 (4.27) 
17.57 (1.50) 
 
 
11.14 (2.91) 
 
7.21 (1.85) 
 
28.83 (7.99) 
 
8.17 (1.47) 
4.17 (3.07) 
 
14.75 (4.50) 
 
47.08 (8.33) 
 
2.58 (2.91) 
 
 
 
2.81 (.77) 
2.22 (.73) 
2.02 (.32) 
 
 
114.33 (18.83) 
20.17 (3.16) 
10.67 (2.57) 
17.50 (3.78) 
17.67 (1.83) 
 
 
11.83 (1.59) 
 
7.83 (.94) 
 
33.57 (12.77) 
 
8.86 (1.46) 
3.21 (2.69) 
 
15.79 (3.68) 
 
52.07 (12.06) 
 
1.50 (1.91) 
 
 
 
3.13 (.60) 
2.19 (.64) 
2.00 (.25) 
 
 
118.33(16.48) 
21.14 (2.68) 
10.36 (2.21) 
18.29 (3.63) 
18.57 (1.22) 
 
 
11.29 (2.84) 
 
7.14 (1.61) 
 
35.17 (10.50) 
 
8.33 (.98) 
3.92 (1.98) 
 
16.83 (3.69) 
 
50.33 (7.64) 
 
2.42 (1.93) 
 
 
 
2.94 (.76) 
1.83 (.52) 
1.98 (.29) 
 
 
118.92 (16.25) 
20.58 (3.03) 
10.92 (2.23) 
19.17 (3.33) 
17.58 (2.31) 
 
 
11.83 (1.75) 
 
7.83 (1.53) 
 
37.36 (12.06) 
 
7.86 (2.14) 
4.79 (1.53) 
 
17.36 (2.59) 
 
52.00 (8.16) 
 
1.57 (2.10) 
 
 
 
3.07 (.69) 
1.97 (.58) 
1.84 (.26) 
 
 
121.86 (21.03) 
21.00 (3.19) 
11.07 (2.92) 
19.93 (3.67) 
17.16 (2.98) 
 
 
11.07 (2.50) 
 
7.07 (1.86) 
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*FEIT: F(2 22) = 6.018, p = .008 (time x group interaction) 
**BTFR: F(1 23) = 2.909, p = .102 (time x group interaction) 
***ECPT: F(1 23) = 8.366, p = .008 (group main effect) 
+SPS Identified Stimuli: F(2 22) = 4.247, p = .028 (time main effect);  F(2 22) = 2.891, p 
= .077 (time x group interaction) 
++SPS Title: F(2 22) = 2.682, p = .091 (time x group interaction) 
±MCAS Total: F(2 22) = 65.402, p < .01 (time main effect) 
±±MCAS Health: F(2 22) = 4.737, p = .019 (time x group interaction) 
±±±MCAS Social Skills: F(2 22) = 2.411, p = .113 (time main effect)   
~AIHQ Aggression: F(2 22) = 2.61, p = .096 (time main effect) 
 
 
Of the 21 ANCOVAs, two yielded a significant time x group interaction effect:  
FEIT (F(2 22) = 6.02, p = .008) (see Figure 5) and the MCAS (Health, F(2 22) = 4.74, p 
= .019) (see Figure 6); neither the main effects for time nor treatment group were 
statistically significant for these measures. Within and between group t-tests for the FEIT 
scores did not identify the source of the significant time x group interaction effect, but 
visual inspection of the mean changes within and between groups suggests that Group 1 
improved immediately after receiving SCIT treatment (Time 1-2 within group t(12)= -
.92, p = .38), but did not sustain that improvement over time as performance declined at 
the final assessment (Time 2-3 within group t(11) = 1.51, p = .16); for Group 2, 
performance declined after receiving TAU (Time 1-2 within group t(17) = 1.14, p = .27 ), 
but improved on the final assessment after receiving SCIT treatment (Time 2-3 within 
group t(13) = -3.56, p = .003).    
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Figure 4.1. Group means for FEIT (adjusted with gender as covariate). 
 
The significant time x group interaction for the MCAS Health (see Figure 4.2) 
indicates that while Group 1 showed neither statistically significant decline nor 
improvement on this measure over time (Time 1-2 within group t(12) = -.46, p = .66; 
Time 2-3 within group t(, Group 2 significantly improved performance after receiving 
TAU (Time 1-2 within group t(17) = -3.22, p = .005) and sustained this improvement 
after completing SCIT treatment (Time 2 -3 within group t(13) = .22, p = .83). Thus, the 
below depicted MCAS Health graph shows the significant interaction was due to a 
change not attributable to SCIT. 
The time x group interactions for two of the Social Perception Scale measures 
(see Figures 4.3 and 4.4 below) indicate trend level statistical significance. The 
interaction effect for SPS Title (F(2 22) = 2.68, p = .091) indicates that Group 1 
improved immediately after receiving SCIT treatment (Time 1-2 within group t(12) = -
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.66, p = .52), but did not sustain that improvement (Time 2-3 within group t(11) = .464, p 
= .65), Group 2’s performance declined after receiving TAU (Time 1-2 within group 
t(17) = .33, p = .75) but improved significantly after receiving SCIT treatment (Time 2-3 
t(1) = -2.75, p = .02) (see Figure 4.3).    
  
Figure 4.2. Group means for MCAS – Health (adjusted with gender as covariate).  
  
Figure 4.3. Group means for SPS title (adjusted with gender as covariate).  
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The trend-level interaction effect for SPS Identified Stimuli (F(2 22) = 2.89, p = 
.077) and indicates that Group 1 performed significantly poorer after receiving SCIT 
treatment (Time 1-2 within group t(12) = 3.61, p = .004) but improved significantly by 
the third assessment (Time 2-3 within group t(11) = -2.38, p = .04),  whereas Group 2 
showed steady improvement over time (Time 1-2 within group t(17) = -.46, p = .65; Time 
2-3 within group t(13) = -1.11, p = .29; Time 1-3 within group t(13) = -1.42, p = .18). In 
addition, the main effect for time was significant for SPS Identified Stimuli (F(2 22) = 
4.25, p = .028) (see Figure 4.4).  
  
Figure 4.4. Group means for SPS Identified Stimuli (adjusted with gender as covariate). 
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The main effect for group was statistically significant for ECPT (F(1 23) = 8.366, 
p = .008), with better overall performance of Group 1 versus Group 2 (see Figure 4.5). 
  
Figure 4.5. Group means for ECPT (adjusted with gender as covariate).  
 
Other significant or trend-level significant main effects for time were found for 
the following measures: MCAS (Total Score: F(2 22) = 65.40, p < .01), with both groups 
improving significantly after Time 1 (see Figure 4.6).  
 
Figure 4.6. Group means for MCAS Total score (adjusted with gender as covariate).  
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The main effect of time reached a trend level of statistical significance for the 
following measures: AHIQ (Aggression: F(2 22) = 2.61, p = .096), with  Group 1’s 
performance initially declining but improving during the last assessment, while Group 2 
improved performance over time (see Figure 4.7);  
 
Figure 4.7. Group means for AIHQ Aggression (adjusted with gender as covariate).  
 
 Hinting Task (F(2 22) = 3.02, p = .096), with both groups showing improved 
performance by the third assessment (see Figure 4.8).  
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Figure 4.8. Group means for Hinting Task (adjusted with gender as covariate).  
 
To further explore the data, these results were further probed with 2x2 
ANCOVAs as well as univariate ANCOVAs. As expected, no mean difference was found 
for Time 1 testing on performance of social cognitive and social functioning outcome 
measures between the two groups (Group 1 = SCIT then TAU;   Group 2 = TAU then 
SCIT). For Time 2 testing, Group 1 is expected to have improved performance after 
receiving SCIT treatment. Results indicate that Group 1 (SCIT first) performed better on 
the following outcome measures as compared to Group 2 (TAU first): BTFR (F(2 28) = 
3.45, p = .046) (see Figure 4.9), SFS Interpersonal Communication (F(2 28) = 3.88, p = 
.033) (see Figure 4.10), and ASQ (F(2 28) = 2.91, p = .071) (see Figure 4.11). No other 
significant mean differences between groups were found. Finally, Group 2 was expected 
to improve performance on outcome measures at Time 3 testing (after also receiving 
SCIT treatment), while Group 1 was expected to sustain level of performance. A 
significant time x group interaction indicating decrease in performance on the FEIT (F(1 
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23) = 12.040, p = .002) for Group 1 while performance for Group 2 improved. A time x 
group interaction for the SPS (Title; F(1 23) = 4.793, p = .039) indicates that Group 2 
demonstrated significant improvement while performance for Group 1 stayed that same. 
Further, a trend-level significant main effect for time for the MCAS (Adaptation; F(1 23) 
= 2.965, p = .099) indicates the groups’ performance improved between the second and 
third assessment (see Figure 4.12).   
 
Figure 4.9. Group means for BTFR (adjusted with gender as covariate).  
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Figure 4.10 .Group means for SFS Interpersonal Communication (adjusted with gender 
as  
covariate). 
 
 
  
 
 
Figure 4.11. Group means for ASQ (adjusted with gender as covariate).  
 
 
      
Figure 4.12. Group means for MCAS Adaptation (adjusted with gender as covariate). 
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Time 3 testing signified post-treatment testing for both groups. As expected, no 
mean difference was found in performance on all social cognition measures between the 
groups during Time 3 testing.  
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Chapter 5 - Discussion 
 
General Discussion 
 This study contributes to the small but growing number of studies testing the 
impact of SCIT and comparable treatment modalities on social cognitive functioning.  
Although a range of treatments exist targeting deficits in cognitive, neurocognitive, 
and/or social cognitive deficits in individuals with severe mental illness, the 
heterogeneity of schizophrenia-spectrum disorders makes it difficult to treat individual 
areas of deficit in a comprehensive yet viable way. SCIT is a promising new approach to 
ameliorate deficits in social cognitive functioning by balancing necessary treatment 
components (i.e. identified deficit domains) with a viable way of administration during a 
typical time frame (20 sessions) via personally relevant and real-world exercises. Thus, 
by targeting “hot cognition,” cognition with personally relevant content, SCIT promises 
to be ecologically valid, increasing the translatability of learned materials between the 
class room and other areas of participants’ lives.  
Findings of the Present Study 
 Of the 40 participants in the final study sample, 65% completed all testing and 
90% completed the SCIT intervention. The rate of attrition (35%) for assessments is high, 
and exceeds the forecast 10% attrition rate. Several factors contributed to this particular 
rate of attrition, including some individuals being discharged to other programs and/or 
moving out of the catchment area, others asked to drop-out as the time commitment was 
too much and/or they lost interest in continued participation. 
 Emotion measures. Three of the five emotion measures used in this study 
showed evidence of a SCIT treatment effect in the domain of emotion perception. This is 
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in line with previous studies where SCIT was administered (Roberts, et al., 2009; Combs, 
et al. 2009).  Other studies targeting social cognitive deficits also found improvement of 
facial affect perception (Wolwer, et al, 2005; Horan, et al. 2009). However, the current 
study did not find sustained improvement in emotion perception. There was a decrease in 
scores for participants in Group 1 between the second assessment (immediately after 
receiving SCIT treatment) and the third assessment (after receiving TAU, without SCIT 
for 3 months). Results showed this pattern of improvement for the FEIT, BTFR, and the 
SPS. Previous studies have found a similar pattern in results; Combs and colleagues 
(2009) found that participants improved on the FEIT immediately after receiving SCIT 
treatment, but did not sustain these improvements at a 6-month follow-up assessment. 
However, the authors did note that, while performance declined significantly, it did not 
decline to baseline and was found to be on par with the non-psychiatrically ill control 
group. The present study generated no evidence for a SCIT treatment effect on the 
BLERT or the VEIT.  
 ToM measures. The results yield only weak support for a SCIT treatment effect 
on Theory of Mind as measured by the hinting task.  Both groups improved somewhat on 
this task by the last (third) assessment, with Group 2 improving performance after 
receiving SCIT treatment. However, Group 1 showed a delayed improvement effect as 
performance initially decreased after receiving SCIT treatment, but subsequently 
increased after receiving TAU. The lack of a statistically significant difference may be 
due to the general high scores achieved on the Hinting Task, which may indicate a ceiling 
effect. This could indicate that this task may be useful for more acutely symptomatic 
inpatients, or more severely disabled institutional patients, but may not measure more 
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nuanced ToM deficits in a stable outpatient population. Other studies testing the 
effectiveness of SCIT on social cognitive deficits, however, did find improved 
performance on ToM measures after participants received the SCIT intervention 
(Roberts, et al., 2009; Combs, et al., 2007; Penn, et al., 2005). It should be considered, 
however, that these studies were conducted in inpatient settings where participants may 
have exhibited greater ToM deficits as measured by the Hinting Task at baseline, 
allowing measurement of possible improvement due to SCIT treatment. 
 Attributional style measures. Results of this study indicate that both groups 
improved in performance on the AIHQ (Aggression subscale) by the third assessment; 
only Group 1 showed improvement on the AHIQ (Blame subscale) immediately after 
receiving SCIT and sustained this improvement at the third assessment.  However, a 
trend level decline in performance on the ASQ was found for both groups on the second 
and third assessment. The groups did not show a significant mean difference in 
performance, indicating no difference in attributional style after receiving SCIT 
treatment. No significant effect was found for either group on the NFCS.   
 Social functioning measures. The current study found participants increased 
their performance on the SFS (interpersonal communication subscale) after receiving 
SCIT treatment; this finding is consistent with previous findings by Combs and 
colleagues (2009).  Participants achieved higher ratings on the MCAS (total score) after 
the first assessment; both groups sustained this improvement at the third assessment. 
Further, both groups showed improvement on the Adaptation subscale of the MCAS 
between the second and the third assessment. Finally, only Group 2 improved their 
ratings on the MCAS (Health subscale) over time.  
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Limitations of the Present Study and Future Directions 
 We designed this study to evaluate a targeted treatment for social cognition 
deficits in a severely mentally ill population in real-world settings. As such, the 
heterogeneity of schizophrenia spectrum disorders in community participants resulted in 
limitations for this study that would not be present in a sample of matched research 
participants. Thus, the quasi-experimental nature of this study may prevent a more 
confident assignment of treatment effects specifically to SCIT, which may be achieved 
via a more rigorously controlled study. The current study serves as a preliminary analysis 
for the implementation of SCIT in outpatient treatment settings.  
 As indicated in previous discussions, results may be impacted from lower than 
expected statistical power; a bigger study sample may allow for more statistically 
significant findings with regards to social cognitive outcome measures. It should be 
considered that the predicted attrition rate was based on previous studies conducted in 
inpatient settings as compared to the outpatient treatment settings in this study where 
ambient expectorations of treatment participation may differ.  In addition, the higher than 
expected rate of attrition was limited to assessment completion (35%), while the expected 
rate of attrition (10%) was found for treatment completion. Although this smaller size 
during the assessment phase may impact statistically significant findings, it does not 
necessarily reflect a less strong treatment effect of SCIT. In light of this discrepancy of 
attrition rate between treatment completion and assessment completion, current findings 
indicate that SCIT should be considered a viable and feasible treatment for social 
cognitive deficits in an outpatient population. Participants appeared to enjoy the treatment 
and the 10% attrition was due to either a change of schedule or a move/discharge of the 
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participant from the treatment site. On the other hand, the higher rate of assessment 
attrition was heavily influenced by the time consuming process of testing (approximately 
4 hours at each testing phase) and the small remuneration ($5 per completed assessment 
phase).  As the demanding testing schedule is not typically not part of the treatment 
process to the extent is was here, the treatment effects documented by this study may be 
more solid for a purely clinical application of the treatment. Overall, a bigger sample size 
and advanced statistical modeling may allow for more nuanced results. As such, the 
present study functions as a precursor allowing and encouraging continued study of 
targeted treatment approaches for social cognitive deficits in an SMI population.  
 Even though the effect sizes for results for social cognitive outcomes measures 
were in the small to medium range, findings from the current study do indicate a 
treatment effect for SCIT. Improvement in some domains (e.g. emotion perception, social 
functioning) replicated findings from previous SCIT studies (Roberts, et al., 2009; 
Combs, et al. 2009) and contribute to the study of treatment effects on specific social 
cognitive domains. However, while finding some indication of a treatment effect, current 
as well as previous outcomes did not necessarily indicate persisting treatment effects 
(Combs, et al., 2009).  This lack of persistent outcome effects may not entirely reflect a 
weak or non-existent treatment effect as it could also be due to longitudinal fluctuations 
in test performance that reflects actual fluctuations in functioning independent of 
treatment effects. Overall, the longitudinal stability of functioning in these domains is not 
well understood and could be interfering with our ability to measures treatment effects. 
More research is needed to further validate and delineate separate social cognitive 
domains. The heterogeneity of schizophrenia-spectrum disorders makes a clear separation 
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of domains rather difficult. However, a steadily growing number of studies in this area 
show promise in establishing a more precise theoretical groundwork.  
 Further, outcomes from the current study indicate that it is in the realm of 
feasibility to administer SCIT in outpatient treatment settings and achieve some clinically 
significant change. If participant enthusiasm for the treatment and the overall level of 
engagement in treatment sessions is any indication for the promise of this targeted social 
cognitive treatment, at least with regards to the feasibility and acceptability, then this 
study established just that. Although these indicators have not been explicitly measured, 
informal feedback from study participants was most uniformly very positive. Participants 
stated that they very much enjoyed the group sessions and many reported that that they 
felt more confident in interpersonal situations and felt that attending SCIT groups helped 
them better connect with others in the treatment setting. In addition, staff observed that 
clients who participated in SCIT treatment groups appeared to enjoy group sessions and 
observed frequent discussions relating to participants’ experiences in group. Positive 
feedback regarding SCIT treatment replicates findings from previous SCIT studies (Penn, 
Roberts, Combs, and Sterne, 2007; Roberts, Penn, and Labate, 2009) and serves as an 
indicator of overall client engagement in treatment. This is especially important with 
regards to the overall higher level of difficulty of keeping SMI clients engaged in 
outpatient treatment (Kreyenbuhl, Nossel, and Dixon, 2009.). 
 This study contributes to the growing body of literature and existing studies 
needed for the establishing the feasibility of this new social cognitive treatment 
intervention. Our findings are encouraging as they reflect a replication of prior studies, 
including the informally assessed level of client engagement and enthusiasm for this 
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treatment modality. The presence of some treatment effects in this study makes a strong 
case for the effectiveness of this treatment, especially in light of the low statistical power 
and the potential of underestimating treatment effects that are present but remain 
statistically undetected. These improvements, especially in functional domains (e.g. as 
measured by the MCAS), are very compelling and make a strong case for going ahead 
with large scale treatment trials.  In that sense, additional studies will be necessary not 
only to replicate findings, but also to determine generalizability of SCIT as well as the 
degree to which beneficial treatment effects are sustained by SCIT participants after 
treatment has concluded.  
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